Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  IDEXX Laboratories    IDXX

IDEXX LABORATORIES (IDXX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

IDEXX Laboratories : to Release 2018 First Quarter Financial Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2018 | 10:23am CEST

WESTBROOK - (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 first quarter financial results for Friday, May 4 before the market opens.

The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Individuals can access a live webcast of the conference call through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year.

The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-800-288-8967 or 1-612-234-9960 and reference confirmation code 447373. Replay of the conference call will be available through Friday, May 11, 2018 by dialing 1-800-475-6701 or 1-320-365-3844 and referencing replay code 447373.

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a member of the S&P 500 Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 7,500 people and offers products to customers in over 175 countries.

Contact:

Kerry Bennett

Tel: 1-207-556-8155

Email: [email protected]

(C) 2018 Electronic News Publishing, source ENP Newswire

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on IDEXX LABORATORIES
04/17IDEXX LABORATORIES : to Release 2018 First Quarter Financial Results
AQ
04/14IDEXX LABORATORIES : to Release 2018 First Quarter Financial Results
AQ
04/12IDEXX LABORATORIES : to Release 2018 First Quarter Financial Results
PR
04/06IDEXX LABORATORIES : U.S. Patents Awarded to Inventors in Maine (April 6)
AQ
03/30IDEXX LABORATORIES : Rover Veterinary Hospital inaugurated to serve pets
AQ
02/23IDEXX LABORATORIES : Study Data from S. Doza and Co-Authors Update Knowledge of ..
AQ
02/23IDEXX LABORATORIES : New Anaplasma Findings Has Been Reported by Investigators a..
AQ
02/20IDEXX LABORATORIES INC /DE : Change in Directors or Principal Officers (form 8-K..
AQ
02/19IDEXX LABORATORIES : to Present at Two Conferences
AQ
02/16IDEXX LABORATORIES : DE MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
More news
News from SeekingAlpha
04/09GlaxoSmithKline Is A Good Buy - Cramer's Lightning Round (4/6/18) 
04/02What's Trending Into Q2? 
04/02A Quantitative Approach To Finding Wide-Moat Stocks 
03/12VALUATION DASHBOARD : Healthcare - Update 
02/27STMicroelectronics Is A Buy - Cramer's Lightning Round (2/26/18) 
Financials ($)
Sales 2018 2 222 M
EBIT 2018 491 M
Net income 2018 364 M
Debt 2018 617 M
Yield 2018 -
P/E ratio 2018 48,37
P/E ratio 2019 40,88
EV / Sales 2018 7,99x
EV / Sales 2019 7,17x
Capitalization 17 129 M
Chart IDEXX LABORATORIES
Duration : Period :
IDEXX Laboratories Technical Analysis Chart | IDXX | US45168D1046 | 4-Traders
Technical analysis trends IDEXX LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 201 $
Spread / Average Target 2,1%
EPS Revisions
Managers
NameTitle
Jonathan W. Ayers Chairman, President & Chief Executive Officer
Brian P. McKeon Chief Financial Officer, Treasurer & Executive VP
Ken Grady Chief Information Officer & Vice President
Jeffrey Thomas Chief Technology Officer & Vice President
Rebecca M. Henderson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IDEXX LABORATORIES26.50%17 129
MEDTRONIC PLC-0.93%108 294
BECTON, DICKINSON AND COMPANY8.79%62 003
STRYKER CORPORATION6.08%61 284
BAXTER INTERNATIONAL3.73%36 060
ESSILOR INTERNATIONAL-0.44%30 813